Post-Hoc Live: How we chose this year's best biotech startups, and how past picks have fared

Each year, the Endpoints newsroom places bets on the 11 private biotech companies that we think are the most promising, the most cutting-edge — and that would leave the biggest crater behind if things go wrong ...